A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.
Clinical trial NCT06719219 · COMPLETED
Trial details
- NCT number
- NCT06719219
- Sponsor
- LimmaTech Biologics AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-07
- Primary completion
- 2026-03-04
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.